Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Gerhard

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Alzheimer'S & Dementia (New York, N. Y.)|December 11, 2020
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) studyRishi J Desai, Vijay R Varma, Tobias Gerhard, et al.
Brain Communications|November 4, 2022
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines studyRishi J Desai, Mufaddal Mahesri, Su Been Lee, et al.
The Lancet. Primary Care|December 19, 2025
Prescription opioid use and opioid use disorder among older adults with HIV in the USA from 2008 to 2021: a retrospective repeated cross-sectional studyStephanie Shiau, Fabrizio Drago, Carolyn W Kinkade, et al.
Molecular Psychiatry|December 28, 2022
Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's diseaseVijay R Varma, Rishi J Desai, Sheeja Navakkode, et al.
JAMA Psychiatry|January 22, 2016
Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysisBritta Galling, Alexandra Roldán, René E Nielsen, et al.
Pharmacoepidemiology and Drug Safety|May 23, 2013
Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia studyNicole Pratt, Morten Andersen, Ulf Bergman, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Alzheimer'S & Dementia (New York, N. Y.)|December 11, 2020
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) studyRishi J Desai, Vijay R Varma, Tobias Gerhard, et al.
Brain Communications|November 4, 2022
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines studyRishi J Desai, Mufaddal Mahesri, Su Been Lee, et al.
The Lancet. Primary Care|December 19, 2025
Prescription opioid use and opioid use disorder among older adults with HIV in the USA from 2008 to 2021: a retrospective repeated cross-sectional studyStephanie Shiau, Fabrizio Drago, Carolyn W Kinkade, et al.
Molecular Psychiatry|December 28, 2022
Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's diseaseVijay R Varma, Rishi J Desai, Sheeja Navakkode, et al.
JAMA Psychiatry|January 22, 2016
Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysisBritta Galling, Alexandra Roldán, René E Nielsen, et al.
Pharmacoepidemiology and Drug Safety|May 23, 2013
Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia studyNicole Pratt, Morten Andersen, Ulf Bergman, et al.
Pageof 10